- Report
- February 2024
- 111 Pages
Global
From €4713EUR$4,750USD£3,912GBP
- Clinical Trials
- December 2024
- 80 Pages
Global
From €1588EUR$1,600USD£1,318GBP
€1985EUR$2,000USD£1,647GBP
- Clinical Trials
- December 2024
- 80 Pages
Global
From €1588EUR$1,600USD£1,318GBP
€1985EUR$2,000USD£1,647GBP
- Clinical Trials
- November 2024
- 180 Pages
Global
From €1985EUR$2,000USD£1,647GBP
€2481EUR$2,500USD£2,059GBP
- Clinical Trials
- November 2024
- 60 Pages
Global
From €992EUR$1,000USD£824GBP
€1240EUR$1,250USD£1,030GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €2977EUR$3,000USD£2,471GBP
€3721EUR$3,750USD£3,089GBP
- Drug Pipelines
- July 2024
- 80 Pages
Global
From €1588EUR$1,600USD£1,318GBP
€1985EUR$2,000USD£1,647GBP
- Report
- June 2024
- 152 Pages
Global
From €6311EUR$6,360USD£5,238GBP
€7889EUR$7,950USD£6,548GBP
- Clinical Trials
- June 2024
- 80 Pages
Global
From €1588EUR$1,600USD£1,318GBP
€1985EUR$2,000USD£1,647GBP
- Clinical Trials
- June 2024
- 60 Pages
Global
From €992EUR$1,000USD£824GBP
€1240EUR$1,250USD£1,030GBP
- Drug Pipelines
- April 2024
- 50 Pages
Global
From €1191EUR$1,200USD£988GBP
€1488EUR$1,500USD£1,235GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €992EUR$1,000USD£824GBP
€1240EUR$1,250USD£1,030GBP
- Drug Pipelines
- April 2024
- 180 Pages
Global
From €2382EUR$2,400USD£1,977GBP
€2977EUR$3,000USD£2,471GBP
- Drug Pipelines
- April 2024
- 75 Pages
Global
From €1588EUR$1,600USD£1,318GBP
€1985EUR$2,000USD£1,647GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1191EUR$1,200USD£988GBP
€1488EUR$1,500USD£1,235GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1588EUR$1,600USD£1,318GBP
€1985EUR$2,000USD£1,647GBP
- Drug Pipelines
- April 2024
- 280 Pages
Global
From €2382EUR$2,400USD£1,977GBP
€2977EUR$3,000USD£2,471GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
€1985EUR$2,000USD£1,647GBP
€2481EUR$2,500USD£2,059GBP
- Report
- April 2024
- 30 Pages
Global
From €2818EUR$2,840USD£2,339GBP
€3523EUR$3,550USD£2,924GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1588EUR$1,600USD£1,318GBP
€1985EUR$2,000USD£1,647GBP
The Antivirals market is a subset of the Infectious Diseases Drugs market, which includes drugs used to treat viral infections. Antivirals are used to treat a wide range of viral infections, including influenza, HIV, herpes, hepatitis, and other respiratory infections. Antivirals work by targeting the virus itself, preventing it from replicating and spreading throughout the body. They can also be used to reduce the severity of symptoms and shorten the duration of the illness.
Antivirals are typically administered orally or intravenously, depending on the type of virus and the severity of the infection. In some cases, antivirals may be used in combination with other drugs to increase their effectiveness.
Some of the major companies in the Antivirals market include Gilead Sciences, Merck & Co., Pfizer, GlaxoSmithKline, and Bristol-Myers Squibb. These companies produce a variety of antiviral drugs, including those used to treat influenza, HIV, herpes, and hepatitis. Show Less Read more